MENU
GRTX
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

Galera Therapeutics (GRTX) Ownership - Who owns Galera Therapeutics?

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
3.92M
P/E Ratio
N/A
Total Cash
10.75M
Projected Growth
N/A
Total Debt
1.19M
Revenue
N/A
Risk (Beta)
2.24
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GRTX
Capitalization
N/A
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
N/A
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
N/A
Total Liabilities
N/A
Total Volume MTD
N/A
Value
N/A
Gain YTD
N/A
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which focuses on the prevention of radiation-induced toxicity

Industry Biotechnology

Profile
Fundamentals
Details